Skip to main content

Table 1 Summary of TCGA pan-cancer data

From: A pan-cancer study of selenoprotein genes as promising targets for cancer therapy

Primary disease type

TCGAID

Total N

Primary tumor

Normal tissue

OS_censored

OS_event

Adrenocortical cancer

ACC

79

79

0

61

34

Bladder urothelial carcinoma

BLCA

430

411

19

242

199

Breast invasive carcinoma

BRCA

1217

1104

113

1035

209

Cervical and endocervical cancer

CESC

309

306

3

227

77

Cholangiocarcinoma

CHOL

45

36

9

38

30

Colon adenocarcinoma

COAD

512

471

41

423

116

Diffuse large B-cell lymphoma

DLBC

48

48

0

39

12

Esophageal carcinoma

ESCA

173

162

11

140

109

Glioblastoma multiforme

GBM

173

168

5

102

547

Head and neck squamous cell carcinoma

HNSC

546

502

44

330

281

Kidney chromophobe

KICH

89

65

24

160

22

Kidney clear cell carcinoma

KIRC

607

535

72

638

341

Kidney papillary cell carcinoma

KIRP

321

289

32

313

65

Acute myeloid leukemia

LAML

151

151

0

168

458

Brain lower grade glioma

LGG

529

529

0

392

141

Liver hepatocellular carcinoma

LIHC

424

374

50

275

188

Lung adenocarcinoma

LUAD

585

526

59

469

269

Lung squamous cell carcinoma

LUSC

550

501

49

403

354

Mesothelioma

MESO

86

86

0

12

74

Ovarian serous cystadenocarcinoma

OV

379

379

0

296

435

Pancreatic adenocarcinoma

PAAD

182

178

4

92

130

Pheochromocytoma and paraganglioma

PCPG

186

183

3

181

8

Prostate adenocarcinoma

PRAD

551

499

52

607

16

Rectum adenocarcinoma

READ

177

167

10

144

34

Sarcoma

SARC

265

263

2

175

112

Skin cutaneous melanoma

SKCM

472

471

1

239

224

Stomach adenocarcinoma

STAD

407

375

32

292

210

Testicular germ cell tumor

TGCT

156

156

0

135

4

Thyroid carcinoma

THCA

568

510

58

592

22

Thymoma

THYM

121

119

2

126

12

Uterine corpus endometrioid carcinoma

UCEC

583

548

35

490

100

Uterine carcinosarcoma

UCS

56

56

0

21

40

Uveal melanoma

UVM

80

80

0

57

23